American Society of Hematology

New Leadership Elected to American Society of Hematology

Published on: November 01, 2017

(WASHINGTON, November 1, 2017) – The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, today announced the election of three new members to its Executive Committee for terms beginning after the 2017 ASH Annual Meeting December 9-12 in Atlanta.

Stephanie Lee, MD, will serve a one-year term as vice president followed by successive terms as president-elect and president. Agnes Lee, MD, and Joseph Mikhael, MD, will each serve four-year terms as councillors.

“In this time of unprecedented scientific progress, ASH continues to play a leading role in ensuring that these research advances are translated to the bedside to improve the care of hematology patients,” said 2017 ASH President Kenneth C. Anderson, MD, of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute in Boston. “It is exciting to have such a diverse and accomplished group of leaders helping to guide the Society as we work with policymakers, educators, researchers, clinicians, patients, and other stakeholders to shape the future of hematology and work toward our ultimate goal of conquering blood diseases worldwide.”

VP S_ Lee

Dr. Stephanie Lee is a member of the Fred Hutchinson Cancer Research Center and a professor at the University of Washington in Seattle. Her research interests include outcomes and health services research in hematologic malignancies and allogeneic hematopoietic cell transplantation, and late effects of hematopoietic cell transplantation, particularly chronic graft-versus-host disease. 

Dr. Lee has been a member of ASH for 22 years, and during that time has served in various leadership roles representing the Society, most recently serving as ASH secretary. She previously chaired the Scholar Awards Program Study Section and has participated in many educational and career development programs. As vice president of ASH, Dr. Lee aims to grow ASH’s programs and activities by investing where ASH can make a difference. She will work to increase public appreciation and understanding of hematology research. She plans to share her rewarding experience at ASH by motivating other members to be more involved in ASH’s activities.

Councillor A_ Lee

Dr. Agnes Lee is a professor of medicine at the University of British Columbia (UBC), director of the Thrombosis Program at Vancouver Coastal Health and UBC, and director of the Hematology Research Program at Vancouver General Hospital. Her research interests include cancer-associated thrombosis, catheter-related thrombosis, anticoagulants, and research methodology. Dr. Lee has been a member of ASH for 19 years. She served as education program co-chair for the 2012 ASH Annual Meeting and has been a program co-chair for Highlights of ASH in North America, Asia, and Latin America. Dr. Lee has also served on the editorial board for ASH’s journal Blood. She is currently a member of the Awards Committee, Small Meetings Oversight Subcommittee, and Guideline Panel on VTE in Patients with Cancer.

Councillor Joe Mikhael

Dr. Joseph Mikhael is a professor of medicine at Mayo Clinic in Arizona, where he is also deputy director of the Mayo Clinic Cancer Center and associate dean at Mayo Clinic School of Graduate Medical Education. Dr. Mikhael’s research interests include multiple myeloma/plasma cell disorders, pharmaco-economics, and education and communication skills in medicine. He has been a member of ASH for 17 years, and has served as education program co-chair for the ASH Annual Meeting, program co-chair for Highlights of ASH in North America, Asia, and Latin America, and co-director of the ASH Clinical Research Training Institute (CRTI). Dr. Mikhael currently serves on the steering committee of the CRTI program and chairs the ASH Committee on Communications. 


The American Society of Hematology (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.  

CONTACT:
Sara Khalaf, American Society of Hematology 
skhalaf@hematology.org; 202-552-4925

back to top